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Neural tube defectsDuring primary neurulation, the separation of a single-layered ectodermal sheet into the surface ectoderm (SE)
and neural tube speciﬁes SE and neural ectoderm (NE) cell fates. Themechanisms underlying fate speciﬁcation in
conjunction with neural tube closure are poorly understood. Here, by comparing expression proﬁles between SE
andNE lineages, we observed that uncommitted progenitor cells, expressing stem cellmarkers, are present in the
neural plate border/neural fold prior to neural tube closure. Our results also demonstrated that canonical Wnt
and its antagonists, DKK1/KREMEN1, progressively specify these progenitors into SE or NE fates in accord with
the progress of neural tube closure. Additionally, SE speciﬁcation of the neural plate border via canonicalWnt sig-
naling is directed by the grainyhead-like 3 (Grhl3) transcription factor. Thus,wepropose that the fate speciﬁcation
of uncommitted progenitors in the neural plate border by canonical Wnt signaling and its downstream effector
Grhl3 is crucial for neural tube closure. This study implicates that failure in critical genetic factors controlling
fate speciﬁcation of progenitor cells in the neural plate border/neural fold coordinated with neural tube closure
may be potential causes of human neural tube defects.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Neural tube defects are severe developmental disorders of the brain
or spinal cord and one of themost commonwith a frequency of about 1
per 1000 births in humans (Mitchell, 2005). It is still unclear howgenet-
ic and environmental factors are associated with human neural tube
defects. Neural tube defects arise when the neural tube fails to close
completely during early embryonic development. Neural tube closure
proceeds progressively at different levels of the anterior–posterior axis
during primary neurulation in which the neural plate bends, folds up
and fuses along the dorsal midline of neural folds.
Notably, neural ectoderm (NE) and surface ectoderm (SE) initially
adjoin within an ectodermal sheet prior to neural tube closure and
thereafter the sheet completely separates the two fates by the end of
neural tube closure. Thus, it can be assumed that fate speciﬁcation
within the ectodermal sheet into NE or SE should be precisely con-
trolled in conjunction with neural tube closure in both time and
space. Indeed, genetic clonal analyses of cell lineage segregations in
the mouse embryo have suggested that ectodermal progenitor cells,
which are not committed to the NE or SE, are present during early tora-Yoshida),
. This is an open access article undermid-gastrulation (Tzouanacou et al., 2009; Lawson et al., 1991). Howev-
er, little is known about what, when, and how molecular mechanisms
control the fate speciﬁcation decision between NE and SE cells in the
neural plate border/neural fold, where these cells adjoin.
Moreover, it is still unknownwhether uncommitted progenitor cells
remain in the neural plate border followingNE and SE speciﬁcation dur-
ing neurulation in vertebrate embryos. Indeed,much attention has been
paid to the neural plate border between the NE and SE in light of the
major source of the neural crest and placodes, and for decades many
studies have explored the mechanisms underlying neural crest speciﬁ-
cation in the neural plate border (Patthey and Gunhaga, 2011;
Sauka-Spengler and Bronner-Fraser, 2008; Grocott et al., 2011;
Steventon et al., 2014; Stuhlmiller and Garcia-Castro, 2012; Weston
and Thiery, 2015).
The present study reveals that the neural plate border possesses an
uncommitted progenitor state prior to the midline fusion of neural
folds during neural tube closure. Our data provide evidence that
canonical Wnt signaling promotes SE speciﬁcation, whereas the Wnt
antagonist, Dickkopf1 (Dkk1), induces NE speciﬁcation in the neural
plate border. Additionally,Grainyhead-like 3 (Grhl3) transcription factor,
which is essential for neural tube closure, speciﬁes the SE cell fate under
the control of canonicalWnt. Thus, we propose that fate speciﬁcation of
the neural plate border/neural fold via canonical Wnt signaling and the
Grhl3 factor is crucial for neural tube closure. This study implicates thatthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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neural tube closure. Moreover, failure in critical factors controlling fate
speciﬁcation of uncommitted progenitor cells in the neural fold
coordinated with neural tube closure may induce human NTDs.
2. Materials and Methods
2.1. Constructions of transgene vectors and generation of transgenic mice
Mouse Dkk1,Wnt8A and Grhl2 cDNA fused to the CAG promoter was
ligated to the LacZ gene ﬂanked by two loxP sequences, as described
previously (Kimura-Yoshida et al., 2005). Mouse Grhl2 and Grhl3
cDNAs were obtained from EMAGE clone #6306106 and #30607679,
respectively. These cDNAs were inserted into the CAG cassettes. These
constructs were microinjected into the pro-nucleus of the fertilized
eggs from CD-1 as described (Nagy et al., 2003)
2.2. Mouse Genotyping
Genotyping of CAG-Dkk1 transgenic mice obtained using the PCR
primers CAG-pro (5′-TAGAGCCTCTGCTAACCATGTTCATGCCTT-3′) and
CAG-Dkk1 (5′-TCAGCGCAAGGGTAGGGCTGGTAGTTGTCA-3′), yielding
443 bp. CAG-Wnt8A transgenic mice were genotyped as described
(Kimura-Yoshida et al., 2005). Dkk1 null mutant mice were identiﬁed
with three primers: mdkk1-5′ (5′-GCAACGCTAAAGGGTTAATCAGCAAC
TATA-3′), mdkk1-frt5′ (5′-CCCCGGGAACTACTGCAAAAATGGT-3′), and
mdkk1-frt3′(5′-GTGCTCAAACACAAGCCAGTGACGA-3′), yielding 180 bp
as the wild-type allele and 400 bp as the mutant allele. Grhl3-Cre-
IRES-nlsLacZ knock-in mice were obtained from the Mutant Mouse Re-
gional Resource Center (MMRRC) and genotyped with the following
primers: Grhl3-cre (5′-AATTAAGAGACGAGTGGTCAGCAGCGCCTG-3′),
Grhl3-cre wt rev (5′-ACCCTTACAAATTGCCGTGTGAATCCGGGC-3′), and
Grhl3-cre mut (5′-GCAGCCCGGACCGACGATGAAGCATGTTTA-3′), yield-
ing 213 bp as the wild-type allele and 370 bp as the mutant allele.
β-Catenin knockout mice were genotyped as described (Kimura-
Yoshida et al., 2005). The CAG-Grhl2 allele was genotyped by PCR of
genomic DNA using the following primers: CAG-pro primer (described
aforementioned) and Grhl2-rev1 5′-CAGATATGACTTCCAGGCCTCATCCT
CACT-3′, yielding 330 bp as a PCR fragment. Rosa GNZ knock-in mice
(Gt(Rosa)26Sortm1Joe/J) were obtained from the Jackson Laboratory
(Stoller et al., 2008). Rosa GNZ mutant mice were identiﬁed with
these primers: forward 5′-CTCCCAAAGTCGCTCTGAGTTGTTATCAGT-3′,
reverse 5′-CAACGCCCACACACCAGGTTAGCCTTTAAG-3′, yielding 265 bp
as the wild-type allele and forward 5′-TCGCTACCATTACCAGTTGGTCTG
GTGTCA-3′ 443 bp as the mutant allele.
2.3. DNA Microarray
Wild-type embryos were dissected in PBS with calcium andmagne-
sium. The embryos were then incubated in pancreatin/trypsin in
calcium- and magnesium-free PBS for dissection. The surface ectoderm
and neural ectoderm at the forebrain level, which does not include
cephalic mesenchymal cells, were isolated using tungsten needles. The
numbers of embryos used for three independent biological replicate ex-
periments were as follows: replicate 1, surface ectoderm 1 (SE1) n =
109, neural ectoderm 1 (NE1) n = 46; replicate 2, SE2 n = 117, NE2
n = 43; and replicate 3, SE3 n = 114, NE3 n = 45. Isolated tissues
were stored at −80 °C after being soaked in RNAlater (Applied
Biosystems). Collected tissues were puriﬁed using a TRIzol-plus puriﬁ-
cation kit (Invitrogen, cat. no. 12183-555). The quality of puriﬁed RNA
samples was conﬁrmed using Experion (BioRad). cRNA was prepared
using the illumine Total Prep RNA Ampliﬁcation Kit (Illumina). Samples
were hybridized to a MouseWG6-v2 array (Illumina) and scanned with
a BeadArray Reader (Illumina). Rawdatawere analyzed using Bead Stu-
dio software (Illumina), and pairwise comparisons were done between
the SE and NE populations for each of the three biological replicates.Wenoted that there was good correspondence between replicated genes
with a two-fold change. The accession number for the microarray data
reported in this paper is GSE67977.
2.4. TEM and SEM
TEM and SEM procedures for mouse embryos followed techniques
previous described (Kimura-Yoshida et al., 2005; Kimura et al., 2000).
2.5. Whole Embryonic Culture
Wild-type and CAG-Dkk1 embryos at the 4- to 5-somite stage were
cultured in DMEM supplemented with 20% fetal bovine serum and 1×
nonessential amino acid in a 5%CO2 incubator at 37 °C.
2.6. Immunohistochemistry
Mouse embryos were dissected and embedded in OCT and frozen
overnight at−80 °C. Cryosections were cut at 10 μm using a Microm
HM500 OM cryostat, mounted onto superfrost slides, and stored at
−80 °C until use. After thawing, the slides were ﬁxed in 4% paraformal-
dehyde in PBS and washed in 0.1% TritonX in PBS (PBT). The sections
were then incubated in blocking solution (1% BSA/10% goat serum/
PBT) for 1 h. Incubation of the primary antibody diluted in blocking
solution was performed overnight, as shown in Fig. S9. Sections were
then washed three times in PBT for 5 min per wash and incubated for
2 h at RT with the second antibody in blocking solution. The sections
were further washed three times with PBT for 5 min per wash and
placed onto slides using a mounting medium. Immunohistochemistry
for whole-mount embryos and parafﬁn embedding sections were
performed as described (Shimokawa et al., 2011).
2.7. Histology, electronmicroscopy, X-gal staining, and in situ hybridization
For the histological analysis, embryos were ﬁxed in Bouin's ﬁxative,
dehydrated, and embedded in paraplast. Serial sections (thickness,
7 μm) were generated and stained with hematoxylin and eosin (HE).
X-gal staining and in situ hybridization were performed as described
(Kimura-Yoshida et al., 2005; Kimura et al., 1997, 2000). The following
template cDNA plasmids were used for the synthesis of the probes:
Foxi2 (nt 1554–2267), Grhl2 (nt 203–603), Grhl3 (nt 207–693), Klf5
(nt 986–1590), Kremen1 (nt 3796–4626), Lrp4 (nt 7220–7720), Lrp5
(nt 2888–3444), Lrp6 (nt 2941–3446), Lrp10 (nt 2542–2941), Twist1
(nt 666–1630), andWnt6 (IMAGE clones 6511061).
2.8. Ethics Statement
All mouse studies followed the fundamental guidelines for proper
conduct of animal experiments and related activities in academic
research institutions under the jurisdiction of theMinistry of Education,
Culture, Sports, Science, and Technology of Japan andwere approved by
institutional committees at the Osaka Medical Center and Research
Institute for Maternal and Child Health for animal and recombinant
DNA experiments.
3. Results
3.1. Uncommitted Progenitor Cells are Present in the Neural Plate Border
Prior to Neural Fold Fusion
During primary neurulation, NE and SE cells adjoin directly within
the same ectodermal sheet, and then the neural plate separates from
the SE during the completion of neural tube closure. First, for the deter-
mination of how and when the cell fate is speciﬁed in conjunction with
epithelial fusion during neural tube closure, the expressions of several
NE and SE markers were analyzed (Fig. 1). We found that NE markers
Fig. 1. Comparative expression analysis with NE, SE, and stem cell markers during primary neurulation. (A) Schematic expression patterns in E8.0 (somite stages 1–3) and E8.25 (somite
stages 3–5) embryos. (B–M,P–R) Images of section (B–E, P, Q) andwhole-mount (F–M, R) immunohistochemistry stained at E8.0 (B, C), E8.25 (D, E) and E8.5 (somite stages 5–8) (F–I, J–M,
R) with Sox2/TROMAI (B, C, E), N-cadherin/TROMAI (D, F–H), N-cadherin/E-cadherin (I), OCT4 (J, K), OCT4/TROMAI/N-cadherin (L, M) KLF5 (P, Q) and SSEA4 (R). (N, O)Wholemount in
situ hybridization using Klf5 probe at E8.5 (dorsolateral view, N; dorsal view, O). Each panel shows a region where neither SE nor NE markers are expressed as dotted lines (C–E) and
arrowheads (F–I). The expression of OCT4, a stem marker, speciﬁcally labels the boundary between NE and SE at E8.5, although the expression level is lower than that of primordial
germ cells (J–M). Klf5, which is a Krüppel-like transcription factor that plays crucial roles in maintaining embryonic stem (ES) cell pluripotency, is expressed in the neural plate border
(arrowheads, N–Q). SSEA4 is a cell surfacemarker of human ES, embryonic germ (EG), and induced pluripotent stem (iPS) cells and is expressed in the proximity of the neural plate border
(arrowheads, R). NPB, neural plate border; PGCs, primordial germ cells. Scale bar represents 300 μm in N; 200 μm in F–J, L, M; 100 μm in B, O, P, R; 50 μm in K, Q; and 20 μm in C–E.
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and E-cadherin are expressed roughly in their respective regions during
early neurulation, between E8.0 and E8.5 (somite stages [ss] 1–3 and
5–8, respectively; Fig. 1A–I). However, the uncommitted progenitors
between SE and NE in the neural plate border/neural fold — where
neither SE nor NE is speciﬁed — are present until the completion of
epithelial fusion (Fig. 1A–I; dotted lines in C–E, arrowheads in F–I).
For themolecular characterization of these uncommitted progenitor
cells, the expressions of several stem cell markers were examined
(Fig. 1J–R). OCT-3/4 expression, a stem cell marker, was detected in
the neural plate border/neural fold, although at a lower level than that
in primordial germ cells (Fig. 1J–M). Two additional stem cell markers,
Klf5 transcripts and its proteins and SSEA-4, were also expressed inthe neural plate border (Fig. 1N–R, arrowheads). Theseﬁndings indicate
that a neural plate border region during neurulation possesses a stem
cell-like character.
To further assess whether these neural plate border progenitors are
relevant to the population of the neural crest, we analyzed the expres-
sion of SOX9, a pre-migratory and post-migratory neural crest marker
(Fig. 2). A very few SOX9-positive cells were located in the neural
plate border at the forebrain (Fig. 2A, E, F). At the hindbrain level, a con-
siderable amount of SOX9-positive cells were delaminated from in the
vicinity of the neural plate border (Fig. 2B, G). However, SOX9-
negative cells appeared to be present and still remained at an uncom-
mitted state at this stage at both the forebrain and hindbrain levels
(Fig. 2F, G, dotted lines). Additionally, given that SOX9-positive cells
Fig. 2.Behaviors of SOX9-positive neural crest cells during neurulation. (A–D)Whole-mount immunohistochemistry stained at E8.5with SOX9antibody. SOX9-positive cells are present in
pre- and post-migratory neural crest cells at the forebrain, hindbrain and trunk levels but fewwere present at the caudal level (A–D). In this study,we deﬁned “trunk” as the anterior spinal
cord level inwhich the neural tube is closed completely, and “caudal” as the caudal spinal cord level inwhich the neural tube is still open. (E–I) Sectional images of immunohistochemistry
at the level of the forebrain (E, F), hindbrain (E, G), trunk (H) and caudal (I) with SOX9 (yellow)/N-cadherin (green)/TROMAI (magenta). At the level of the hindbrain, SOX9-positive cells
were present in the proximity of the neural plate border (G; white dotted lines). Dottedwhite lines indicate the neural plate border. NCs, neural crest cells. Scale bar represents 200 μm in
A–E; 50 μm in F–I.
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able at the caudal level, neural crest cells are not directly from the
uncommitted progenitors in the neural plate border during neurulation
at the trunk and caudal levels (Fig. 2C, D, H, I).These ﬁndings indicate that although uncommitted progenitor cells
in the neural plate border contributed to neural crest lineages to some
extent (at least at the level of the hindbrain), the decision of fate speciﬁ-
cation to the neural crest appears to be not intimately linked to neural
517C. Kimura-Yoshida et al. / EBioMedicine 2 (2015) 513–527tube closure. Taken together, the fate speciﬁcation to SE orNE in the neu-
ral plate border appears to be intimately coupled to neural tube closure.
3.2. Wnt Signaling Modulators DKK1 and KREMEN1 are Localized at the
Neural Plate Border
To identify what types of signaling pathways are involved in the fate
speciﬁcation between SE and NE cells during neurulation, we carefully
separated the SE and NE from the forebrain level of mouse embryos at
E8.25–E8.5 (pooled samples from 3- to 5-somite stage embryos;
three biological replicates) and compared the whole genome-wide
gene expression proﬁles bymeans of DNAmicroarray (Fig. S1). Initially,
we surveyed the Wnt, FGF, and BMP ligands, which are thought to
be involved in the speciﬁcation between neural and epidermis fates
prior to or during gastrulation in other vertebrates (Murry and Keller,
2008).
The expression proﬁles of signal transduction-related genes showed
that the expression of Wnt-related molecules is upregulated or down-
regulated between SE and NE, apparently depending on their functions
(Fig. S1). In contrast, the expression of other ligands, BMP and FGF, was
observed exclusively in the SE and NE, respectively. The subsequent
expression analysis with whole-mount in situ hybridization indicated
that Wnt ligands, co-receptors, and receptors were actually expressed
in the proximity of the neural plate border between the SE and NE
(Fig. 3A–W).
To explore the roles of Wnt signaling in fate speciﬁcation, we
examined the protein expressions of DKK1 and KREMEN1, which are
antagonists/modulators for canonical and noncanonical Wnt (Glinka
et al., 1998), more precisely (Fig. 3X-i). DKK1 proteins were detected
in the neural plate border at both the cranial and caudal levels during
neurulation (Fig. 3X-c; arrowheads). This local DKK1 expression was
not observed in the Dkk1 knockout mouse embryo (Fig. 3d, e). Concur-
rently, KREMEN1 proteins as well as its transcripts were localized
speciﬁcally at the neural plate border (Fig. 3U–W, f–i; arrowheads).
Similarly, SFRP1 and LRP5 proteins, an antagonist and co-receptor of
canonicalWnt, respectively, were also prominently localized in the neu-
ral plate border (Fig. 3j–l). Together, these ﬁndings suggested that Wnt
signaling is one of the candidate pathways controlling the speciﬁcation
between NE or SE fate in uncommitted progenitors during neural tube
closure.
3.3. Canonical Wnt Signaling Promotes the SE Fate in the Neural Plate
Border During Primary Neurulation
To determine whether Wnt signaling affects these two cell fates, we
generated transgenic mice misexpressing Dkk1 (Fig. 4A). To create
Dkk1-misexpressing embryos, we crossed the CAG-loxP-lacZ-loxP-Dkk1
transgenic mouse — in which the lacZ gene is ﬂanked by two loxP sites
and the Dkk1 cDNA is misexpressed under the control of the CAG pro-
moter —with the β-actin-cre transgenic mouse (Fig. 4A). The resultant
double-transgenic embryos expressed the Dkk1 protein ectopically
(CAG-Dkk1) (Kimura-Yoshida et al., 2005). Despite rather ubiquitous
Dkk1 misexpression, given that the inhibitory effect on Wnt signaling
through Dkk1 appears to require Kremen1/2 co-receptors and Lrp5/6
receptors (Cruciat and Niehrs, 2013),Dkk1will attenuateWnt signaling
notably in local areas where Kremen1/2 and Lrp5/6 as well as Wnt
ligands are expressed during neurulation (Fig. 3).
Morphological abnormalities in CAG-Dkk1 embryos were detectable
around E8.5. Notably, the forebrain appeared to be expanded (Fig. 4B′)
and the growth of the forelimbs and hindlimbs was greatly diminished
in CAG-Dkk1 embryos at E18.5 (Fig. 4C′). Considering the effects of Dkk1
deﬁciency, which exhibits ectopic digits and forebrain reduction
(Mukhopadhyay et al., 2001), the CAG-Dkk1morphological deformities
also support the notion that the effect of Dkk1 misexpression is the
inverse of the effect of Dkk1 deﬁciency. Concurrently, the expressionpatterns of the canonical Wnt markers β-catenin and Top-gal reporter
were down-regulated inDkk1-misexpressed embryos (Fig. S2A-F, A′–F′).
To explore the possibility that Dkk1 can affect the speciﬁcation
between NE- and SE cell fates, we examined molecular markers in
CAG-Dkk1 embryos with high-resolution immunohistochemistry
(Fig. 4D–K′). TheNEmarkers SOX2,N-cadherin, and Tuj1were localized
in the NE as they are normally (Fig. 4E–H), but they were also found
ectopically in the presumptive SE region in the CAG-Dkk1 embryos
(Fig. 4E′–H′; arrowheads). Conversely, the SE markers E-cadherin and
TROMAI were severely reduced in the SE region of the CAG-Dkk1 em-
bryos (Fig. 4I′–K′). Together these ﬁndings suggested that Dkk1
misexpression promotes the speciﬁcation of NE fate and inhibits that
of SE fate in the neural plate border.
Consistentwith the abovemolecularmarkers, the presumptive SE of
CAG-Dkk1 embryos was transformed from a simple epithelium to a
pseudostratiﬁed- or stratiﬁed-like epithelium (Fig. S3A–C′). To analyze
the histological abnormalities of SE and NE in CAG-Dkk1 embryos
more precisely, we examined their ﬁne structures by means of conven-
tional scanning electron microscopy (SEM) and by viewing ultra-thin
sections using transmission electron microscopy (TEM) (Fig. S3D–H′).
In the wild-type embryos at E8.5, the morphological features of the SE,
neural plate border and NE regions were distinct, and the neural plate
border, previously referred to as “ﬂattened cells” extended to the end
of neural folds along with the longitudinal axis (Fig. S3D, E; ﬂattened
border cells in blue, NE in pink and SE in yellow, respectively)
(Waterman, 1976). In contrast, ﬂattened cells in the neural plate border
between the NE and SE of the CAG-Dkk1 embryos became unclear, and
the morphological features of the border region were more similar to
those of the NE (Fig. S3D′–H′; the border region in green). Together,
the ﬁne morphological analyses suggested that in the CAG-Dkk1
embryos, the medial SE region, which is derived from the neural plate
border, possessed the characteristics of NE.
In addition, our developmental studies of the CAG-Dkk1 embryos using
an in vitro culture system indicated that the timing of the neural tube clo-
sure appeared to be delayed in the CAG-Dkk1 embryos (Fig. S3I–K′). The
telencephalic neuropore, which closes nearly within 6 h in the wild type
(ss 3–4; Fig. S3I–K), was still open and extended laterally after 6 h of cul-
ture in the CAG-Dkk1 embryos (Fig. S3I′–K′). This ﬁnding suggests the
possibility that altered cell fate speciﬁcation of the neural plate border in
CAG-Dkk1 embryos can affect the timing of the neural tube closure.
To investigatewhetherDkk1deﬁciencymay have the opposite effect
on the speciﬁcation between SE and NE, we analyzed Dkk1 null mutant
embryos with speciﬁc markers (Fig. 4L–X, Fig. S2D′′–F′′) (Pietila et al.,
2011). TheNEmarkers SOX2 andN-cadherinwere signiﬁcantly reduced
in the Dkk1−/− embryos at E8.5 (Fig. 4M′, N′, Q, R). Conversely, the SE
markers Tfap2c and TROMAIwere upregulated in theDkk1−/− embryos,
and they were also ectopically found in the presumptive NE region at
both E8.25 and E8.5 during neurulation (Fig. 4O′, S, T, U′, V, W′, X;
arrowheads). These ﬁndings demonstrate that the anterior neural plate
border in Dkk1-deﬁcient embryos was speciﬁed into an SE cell fate at
the expense of an NE cell fate, and that these are the inverse of the
ectodermal phenotypes in Dkk1-misexpressing embryos (Fig. 4E′–K′).
To determine whether these two cell fates can be affected by canon-
icalWnt,we generated transgenicmice inwhichWnt8A, a canonicalWnt
ligand, is ubiquitouslymisexpressed (Fig. S2G–P). Indeed, the expression
domain of β-catenin and Top-gal reporter expression were greatly ex-
panded to the most anterior end of the SE inWnt8A-misexpressed em-
bryos compared to the wild-type embryos (Fig. S2A″–C″,D‴–F‴),
indicating enhancement of canonical Wnt activity. In accord with the
hypothesis that the speciﬁcation between NE and SE fates is altered,
the NE markers Sox2 and N-cadherin were down-regulated (Fig. S2K,
L), whereas the SE markers Tfap2c, E-cadherin, and TROMAI were
enhanced byWnt8Amisexpression (Fig. S2H′, I′, M–P). Together these
ﬁndings strongly suggest that canonical Wnt signaling is crucial to
speciﬁcation of the SE fate from uncommitted progenitors in the neural
plate border.
Fig. 3.Wnt signaling-related genes are expressed in the proximity of the neural plate border. (A–W)Whole-mount in situ hybridization analysis (A–U) and its sectional views (V, W) of
wild-type embryos at E8.25 (D, E, U–W), E8.5 (A, B, F,M–P, S, T) and E8.75 (C, G–L, Q, R). Lateral views (A, C, D, F, G, I, K,M, O, Q, S, U), frontal views (B, H, L, N, P, R, T), and dorsal view (E, J).
sFRP1 (A–C), sFRP2 (D–F),Wnt5A (G,H),Wnt6 (I, J),Wnt4 (K, L), Lrp6 (M,N), Lrp5 (O, P), Lrp4 (Q, R), Lrp10 (S, T) andKremen1 (U–W). (X-l) Immunohistochemical analyses ofwhole-mount
embryos (X-a, f, g, j–l) and transverse sections (b–e, h, i) in wild-type (X-c, f–l) and Dkk1−/− embryos (d, e). DKK1 (X-e; magenta), KREMEN1 (f–i; green), SFRP1 (j; magenta) and LRP5
(k, l; green) proteins are localized at the neural plate border (white arrowheads in c and i), and DKK1 expression is not detected in the Dkk1−/− embryos (d, e). NE, neural ectoderm; SE,
surface ectoderm. Scale bars: 300 μm in A, C, D, F, G, I, K, M, O, Q, S, U; 200 μm in j–l; 100 μm in B, E, H, J, L, N, P, R, T, V-a, f–h; 50 μm in b, d, e; 20 μm in c, i.
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Neural Tube Closure
To identify the transcriptional factors that can mediate the fate
speciﬁcation of SE cells, we re-surveyed the expression proﬁles of theDNA microarrays (Figs. S4, S5). In particular, we focused on SE-speciﬁc
transcriptional factors under the control of canonical Wnt signaling. In
the microarray, 151 genes were more highly expressed in the SE than in
the NE (fold change N3 and p-value b0.05). Of these 151 genes, 20 are
considered transcriptional factors, based on GO slim ontology (Fig. S5).
Fig. 4.Molecular marker analyses in CAG-Dkk1 and Dkk1−/−mutant embryos. (A) A schematic construct of the CAG-Dkk1 transgene. (B–C′, L) The gross appearances of wild-type (B, C),
CAG-Dkk1 (B′, C′), and Dkk1−/− (L) embryos at E8.5 (B, B′, L) and E18.5 (C, C′). (D, P) Transverse sections of embryos. Each section plane is represented by a corresponding line in the
scheme in CAG-Dkk1 (D) and Dkk1−/− (P). (E–K′, Q–X) Immunohistochemical analyses with frozen sections of the wild-type (E–K), CAG-Dkk1 (E′–K′), and Dkk1−/− (Q–T) and with
whole embryos of the wild-type (U, W) and Dkk1−/− embryos (U′, V, W′, X) at E8.5 (E–K′, Q–T), E8.25 (U–V) and E8.75 (W–X). SOX2 (E, E′, Q), N-cadherin (F–G′, R), Tuj1 (H, H′),
E-cadherin (I, I′), TROMAI (J–K′, S–V), and KERATIN17/19 (W, X) merged with nuclei staining (TOTO-3; magenta in E-H′, J–K′, Q–T; blue in U–X). (M–O′) Whole-mount in situ hybridi-
zation in the wild-type (M–O) and Dkk1−/− embryos (M′–O′) at E8.5. Lateral and frontal views of Sox2 expression (M–N′) with sectional views and lateral views of Tfap2c expression
with their frontal views (O, O′). Scale bars: 3 mm in C, C′; 300 μm in B, B′, L–O′, W–X; 100 μm in E–F′, H, H′, J, J′, Q–U′; 10 μm in I, I′, K, K′.
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(Tcfcp2I3), which was upregulated over sixfold more in SE than in NE
(Fig. S5; red letters).The Grhl family of CP2 transcription factors consists of important
regulators of epidermal development in diverse species: grainyhead
(grh) is a key determinant of epidermal barrier formation, wound
520 C. Kimura-Yoshida et al. / EBioMedicine 2 (2015) 513–527healing, tube size, and neuroblast development in Drosophila, and Grhl
genes play crucial roles in epidermal differentiation as well as neural
tube closure in mammals (Pyrgaki et al., 2011; Rifat et al., 2010;
Werth et al., 2010). In addition to Grhl2, Grhl3 is also expressed during
epidermal maturation (Auden et al., 2006) and genetically interacts
with the Grhl2 gene to achieve neural tube closure (Rifat et al., 2010).
Hence, Grhl3 is likely to be another candidate for SE speciﬁcation via
Wnt signaling.Fig. 5.Grhl genes are expressed in the prospective SE. (A–N) In situ hybridization of whole-mou
(A, H), E7.5 (B, I), and E7.8 (C–G, J–N). Lateral view (A–C, H–J), frontal view (D), and caudal vie
(X) at E8.0 (O, P, R), E8.25 (S, U, Y), and E8.5 (Q, T, V, Z). (W) A section plane (X) is indicated
antibody (R–T: GRHL3, magenta; nuclei, blue) in wild-type (O–Q) and Grhl3cre-nZ/+ (R-a). (U–X
(Y-a) DKK1 (magenta; dotted lines), β-gal (GRHL3, green; arrowheads) and nuclei (DAPI, blueTo test the possibility that these Grhl genes can contribute to the fate
speciﬁcation of SE cells in conjunction with neural tube closure, we ﬁrst
examined the expression of Grhl2 and Grhl3 transcripts with in situ
hybridization from the late gastrula to neurula stages (Fig. 5A–N). At
the early to late bud stages, Grhl2 transcripts were detected in the
most proximal-embryonic region, and the expression domain became
restricted to the prospective border of the NE and SE in the rostral
region (Fig. 5A–G), whereas Grhl3 was preferentially expressed in thent embryos (A–D, H–K), sagittal sections (E, L), and transverse sections (F, G,M, N) at E7.25
w (K). (O-a) Whole-mount immunoﬂuorescent staining (O–V, Y-a) and sectioning image
in the schematic. Expression of GRHL2 (O–Q: GRHL2, green; nuclei, magenta) and β-gal
) β-gal (GRHL3; green) and GRHL2 (magenta) merged with DAPI staining (nuclei, blue).
). Scale bars: 300 μm in A–E, H–L; 100 μm in F, G, M–V, Y-a; 10 μm in X.
521C. Kimura-Yoshida et al. / EBioMedicine 2 (2015) 513–527more caudal border between the NE and SE, where the levels of Grhl2
transcripts were rather low (Fig. 5H–N).
Considering that canonical Wnt promotes the SE fate within the un-
committed neural plate border (Fig. 4, Fig. S2), we testedwhether Grhl2
and –3 factors are upregulated in the neural plate border in conjunction
with neural tube closure (Fig. 5O–a). Grhl2 proteinswere found broadly
throughout the cranial SE cells already from the head fold stage
(Fig. 5O–Q; green) before the neurulation stage and continuing after
the neural tube closure stage, mostly co-localized to the TROMAI-
positive cells. On the other hand, Grhl3-β-gal expression, which is
marked by Cre-IRES-NLS LacZ driven by the Grhl3 locus (Camerer
et al., 2010), was not detected at the early somite stage (Fig. 5R). At
the initiation of neural plate folding, Grhl3-β-gal appeared to form a
line of dots along the border, and the expression appeared to increase
in the midline region from the most rostral to the caudal direction
(Fig. 5S, T; magenta). Compared to GRHL2, GRHL3 was evident in the
proximity of the neural plate border between SE and NE (Fig. 5U–X).
These ﬁndings indicated that GRHL2 is expressed in SE cells from the
early stage irrespective of the epithelial fusion of the neural folds and
that GRHL3 is upregulated in the neural folds in conjunction with the
neural tube closure event. To further address whether the DKK1-
positive sharp boundary can demarcate the GRHL3-positive cells, we
examined the expression of GRHL3 and DKK1 proteins and found that
the Grhl3 products were located consistently on the SE side of the
sharp boundary delineated by DKK1 products (Fig. 5Y, Z, a). These
expression data suggest the possibility that Grhl3mediates the SE fate
speciﬁcation of uncommitted progenitor cells via canonical Wnt
signaling in coordination with the dorsal midline epithelial fusion of
neural folds.
3.5. The Grhl3 Gene is Necessary to Specify the SE Fate of Uncommitted
Progenitors
To address whether Grhl3 promotes the SE fate of uncommitted
progenitors marked by DKK1/KREMEN1, we examined the lineage of
SE cells in the Grhl3 null mutant background (Camerer et al., 2010). No-
tably, in the absence of Grhl3 function (Grhl3cre-nZ/cre-nZ), the prospective
SE cells, which are labeled by IRES β-gal expression driven by the
endogenous Grhl3 promoter, were ectopically found within the neural
tissue (Fig. 6A′–C′). Next, to examine whether the mis-localized β-gal-
positive cells possess NE or SE character, we performed amarker analy-
sis with immunohistochemistry (Fig. 6D–E′). Normally, at E8.5 the
neural tube at the levels of the hindbrain and anterior spinal cord is
largely closed and TROMAI-positive SE cells and N-cadherin-positive
NE cells are exclusively separated into surface and neural tube layers
in wild-type embryos (Fig. 6D). However, β-gal-positive Grhl3 hetero-
zygous mutant cells within the SE region ectopically expressed
N-cadherin in addition to TROMAI (Fig. 6E).
Moreover, β-gal-positive Grhl3-deﬁcient cells were often observed
within NE tissues in Grhl3cre-nZ/cre-nZ embryos and appeared to express
N-cadherin but not TROMAI (Fig. 6E′). These results suggest that
β-gal-positive cells appeared to specify into NE cells when the Grhl3
gene dosage was reduced, and thus that Grhl3-deﬁcient cells tend to
be mis-speciﬁed into the NE fate. In addition, uncommitted progenitor
cells, which are speciﬁed into neither NE nor SE and which are marked
by TROMAI-negative and N-cadherin-negative cells, were increased in
Grhl3-deﬁcient embryos (Fig. 6F′).
To determine whether GRHL3-positive cells are relevant to neural
crest cells, we investigated SOX9 expression (Fig. 6G–M′). Most of the
GRHL3/β-gal-positive cells did not contribute Sox9-expressing neural
crest cells in the Grhl3 heterozygous or homozygous mutant embryos
at the level of the forebrain and caudal spinal cord (Fig. 6G–M′). In
addition, these neural crest cells appeared to be unaffected by Grhl3-
deﬁciency (Fig. 6G–M′). Taken together, the present results indicate
that Grhl3 primarily participates in SE fate speciﬁcation in the neural
plate border in conjunction with the epithelial fusion of neural folds.3.6. Grhl3 Interacts Genetically with the Canonical Wnt Pathway in Terms
of SE Speciﬁcation
To validate whether Grhl3 expression is controlled by Wnt signaling,
we ﬁrst analyzed this expression inDkk1-deﬁcient embryos (Fig. 7A–E′).
In theDkk1−/− embryos, theGrhl3 transcripts and protein productswere
ectopically expanded to the entire neural plate border at the forebrain
level (Fig. 7A–E′; arrowheads in A′–C′; arrows in E′). Next, to investigate
whether the regulatory mechanism by Wnt signaling depends on the
transcription level through cis-elements of the Grhl3 gene, we surveyed
the mouse Grhl3 intron 15th, which is highly conserved among
vertebrates and carries the enhancer activity in the zebraﬁsh periderm
cells at the early gastrula stage (de la Garza et al., 2013).
The transgene construct that harbors the conserved Grhl3 15th
intron region linked to a reporter gene, lacZ, was constructed, after
which transgenicmouse lineswere generated and theβ-gal reporter ac-
tivity of F1 transgenic embryos was analyzed (Fig. 7F–G′). Consequent-
ly, the transgenedisplayed the enhancer activity in the SE at the levels of
the hindbrain and spinal cord, but not at that of the forebrain, which ap-
pears to recapitulate the endogenous Grhl3-lacZ knocked-in expression
patterns at E8.25 (Figs. 6A–C, 7G, H). To further test whether this
enhancer activity can be affected by Dkk1 expression, we examined
the reporter activity in the Dkk1-deﬁcient-background and found that
it was enhanced in the SE of the forebrain aswell as in those of the hind-
brain and spinal cord (Fig. 7G′). These precise expression studies
together suggest that Grhl3 expression in the neural plate border during
neural tube closure is regulated by canonical Wnt signaling at the level
of transcription.
To further investigate whether phenotypic defects in the
Dkk1-deﬁcient embryos are partly brought about by the ectopic expres-
sion of the Grhl3 gene due to increased canonical Wnt signaling, we
crossed Grhl3 mutant mice with Dkk1 mutant mice and examined
whether a reduction in the Grhl3 gene dosage could rescue the anterior
defects of Dkk1-deﬁcient embryos (Fig. 7I–L″). Consequently, anterior
NE marked by Six3, Foxg1, and Emx2 was partly restored in Dkk1−/−
embryos by reducing one copy of the Grhl3 gene (Fig. 7I″–K″).
Concurrent with the alteration in NEmarkers, the expanded expression
of Tfap2a, an SE marker at the level of the forebrain (Fig. 7L′), was
reduced toward the normal condition in the Dkk1−/−; Grhl3+/cre-nZ
embryos (Fig. 7L″). These ﬁndings indicate that the reduction in Grhl3
activity can partly compensate for a failure in anterior development
due to Dkk1 deﬁciency. They also support the idea that Dkk1 promotes
NE speciﬁcation by repressing Grhl3 expression in the neural plate
border.
To test the relationship between canonical Wnt signaling and Grhl3
genetically in terms of neural tube closure, we generated the compound
mutant Grhl3; β-catenin by crossing double heterozygous mice
(Fig. 8A–C‴). The Grhl3+/cre-nZ embryos did not exhibit neural tube
defects, whereas theGrhl3cre-nZ/cre-nZ embryos displayed neural tube clo-
sure defects; all embryos had thoraco-lumbo-sacral spina biﬁda and a
curled tail (100%), but only a small fraction of embryos also exhibited
exencephaly (5.5%) (Fig. 8A, B′, C′) (Rifat et al., 2010; Ting et al.,
2003). TheGrhl3cre-nZ/cre-nZ; β-catenin+/− embryos exhibited fully pene-
trant spina biﬁda, similar to Grhl3cre-nZ/cre-nZ alone, butmore than half of
the embryos displayed exencephaly (55.0%) (Fig. 8A, B″, C″). In addition,
Grhl3+/cre-nZ; β-catenin+/−mutant embryos showed the thoraco-lumbo-
sacral spina biﬁda phenotype, although penetrance was not high (curled
tail 8.7%; curled tail and spina biﬁda 4.3%) (Fig. 8A, B‴, C‴). The enhanced
manifestations of neural tube defects in the Grhl3 and β-catenin double-
mutant embryos provide compelling evidence of a positive genetic inter-
action between the canonical Wnt pathway and Grhl3. Our data further
support the notion that canonical Wnt signaling is epistatic to the Grhl3
gene.
To further conﬁrm whether β-catenin itself plays crucial roles in
neural tube closure speciﬁcally within the GRHL3-positive uncommitted
progenitor cells, we analyzed the conditional knockout (CKO) mutation
Fig. 6. SE in the neural plate border is converted into theNE fate in theGrhl3mutant embryos. (A–C′) Lineage analysis ofGrhl3 expression inGrhl3+/cre-nZ (A–C) andGrhl3 cre-nZ/cre-nZ (A′–C′)
embryos at E8.25 with X-gal staining. Transverse sections counterstained with eosin (C, C′). (D, E, E′) Immunohistochemical analyses of whole embryo (D) and frozen section (E, E′)
at E8.25 in wild-type (D), Grhl3cre-nZ/+ (E), and Grhl3cre-nZ/cre-nZ (E′) embryos. β-gal (GRHL3, green), N-cadherin (magenta), TROMAI (blue), and DAPI (cyan). β-gal-positive cells express
N-cadherin in addition to TROMAIwithin the SE layer inGrhl3 heterozygousmutant embryos (E).β-gal-positive cells aremislocalizedwithin the NE tissue inGrhl3 null embryos (E′, white
arrowheads). (F, F′) Immunohistochemical analyses of whole embryos at E8.5 in wild-type (F) Grhl3cre-nZ/cre-nZ (F′). DAPI (green), N-cadherin (blue), and TROMAI (magenta) in F and F′.
N-cadherin-negative and TROMAI-negative cells correspond to uncommitted neural border progenitor cells (green; arrows in F and F′). (G–M′) Immunohistochemical analysis with a neural
crestmarker, SOX9usingwhole-mount embryos (G–J′) and frozen sections (K–M′) inGrhl3cre-nZ/+ (G–M)andGrhl3cre-nZ/cre-nZ (G′–M′). SOX9 (yellow),β-gal (GRHL3, green), TROMAI (magenta)
and nuclei (DAPI, blue). Regarding cell behaviors of the SOX9-positive neural crest, a clear difference was not detected between heterozygous and homozygous mutant embryos. Scale bars:
300 μm in A, A′; 200 μm in D–F′; 100 μm in C, C′, G–J′; 20 μm in K–M′.
522 C. Kimura-Yoshida et al. / EBioMedicine 2 (2015) 513–527of ﬂoxed-β-catenin driven by Cre recombinase from the Grhl3 locus
(Fig. 8D–J′). Consistent with the notion that Grhl3 is expressed only in
the prospective SE of the neural plate border at E8.5 (Figs. 5, 8D–F), β-
catenin expression was speciﬁcally lost in the SE but not the NE of the
neural plate border (Fig. 8F′). β-catenin-CKO embryos displayed spina
biﬁda closely resembling that of the Grhl3 cre-nZ/cre-nZ embryos (Fig. 8B′,
C′, G′–I′).
In agreement with the above hypothesis that canonical Wnt signal-
ing regulates the fate speciﬁcation of uncommitted progenitors in the
neural plate border, in the β-catenin-CKO embryos these progenitor
cells, which are marked as TROMAI-negative and N-cadherin-negativecells, appeared to be increased compared to the wild type (Fig. 8J′).
Together with the above two lines of evidence that Grhl3 expression
in the neural plate border is regulated at the transcriptional level
by the canonical Wnt signaling (Fig. 7A–G′) and that the defects in
fate speciﬁcation observed in the Dkk1-deﬁcient embryos can be re-
stored by the removal of Grhl3 gene dosage (Fig. 7I–L″), these ﬁndings
strongly suggested that Grhl3 and β-catenin genetically interact to
achieve correct closure of the neural tube primarily in the fate speciﬁca-
tion of neural plate border cells. These results also support that
the Wnt antagonists DKK1 and KREMEN1 may be required to maintain
an uncommitted progenitor state and/or to keep away from SE
Fig. 7. The expression of the Grhl3 gene in the neural plate border is controlled by Dkk1 during primary neurulation. (A–C′) In situ hybridization of whole-mount embryos at E7.8 (A–B′)
and E8.5 (C, C′). Expression of Grhl3 transcripts in wild-type (A, C) and Dkk1−/− (A′–C′). (D, E′) Immunohistochemistry of whole-mount wild-type (D, E) and Dkk1−/− embryos (D′, E′).
GRHL3 (magenta) and nuclei (DAPI, blue). Both Grhl3 transcripts and proteins are ectopically expressed in the rostral neural plate border (A′–E′). (F) Schematic diagram of the mouse
Grhl3-endogeneous (from−1.0 kb to 0)/or hsp promoter construct. The 15th intron region (2.35 kb; SalI–BglII), which is conserved among vertebrates, fused with the β-gal cassette.
(G, G′, H) The expression ofβ-gal proteins carrying the transgenic #2 construct appears to recapitulate the endogenousGrhl3 expression in thewild-type (G,H) andDkk1−/− (G′) embryos.
(I–L″) The reduction of Grhl3 gene dosage can partly rescue the forebrain defects inDkk1−/− embryos at E8.25 (I–I″) and E8.5 (J–L″). Whole-mount in situ hybridization (I–K″) and immu-
nohistochemistry (L–L″) in wild-type (I–L), Dkk1−/− (I′–L′), and Dkk1−/−;Grhl3+/cre-nZ (I″–L″). Six3 (I–I″), Foxg1 (J–J″), Emx2 (K–K″), and TFAP2A (L–L″). Scale bars: 300 μm in A–C′, I–K″;
200 μm in D–E′, G, G′, H; 100 μm in L–L″.
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ipates in SE speciﬁcation by activating Grhl3 expression (Fig. 9, see
Discussion).
4. Discussion
In this study, we observed genetic mechanisms underlying the fate
speciﬁcation of uncommitted progenitor cells in the neural plate
border/neural fold coordinately coupled to neural tube closure in both
time and space (Fig. 9). Notably, the Grhl3 transcription factor canpromote the SE fate as one of the downstream effectors of canonical
Wnt signaling. Given that Grhl3 directly contributes to neural tube clo-
sure genetically interacting with β-catenin, we propose that the fate
speciﬁcation of uncommitted progenitor cells in the neural plate border
by canonical Wnt signaling and Grhl3 is crucial for neural tube closure
(Fig. 9).
The results of the present study showed that the speciﬁcation of pro-
genitor cells into the NE or SE fate is progressively controlled in both
time and space by canonical Wnt and its antagonists during neural
tube closure (Fig. 9A). Prior to the fusion of neural folds, the neural
Fig. 8. Grhl3 genetically interacts with β-catenin for the SE speciﬁcation. (A) The number of E11.5 embryos of each genotype frommating crosses between Grhl3+/cre-nZ; β-catenin+/− and
Grhl3+/cre-nZmice and the frequency with which penetrance shows neural tube defects, respectively (n= 155). (B–C‴) Neural tube defects of the compoundmutants of Grhl3; β-catenin.
Gross appearance of Grhl3mutant and Grhl3; β-catenin double-mutant embryos. Wild-type (B, C), Grhl3cre-nZ/cre-nZ (B′, C′), Grhl3cre-nZ/cre-nZ; β-catenin+/− (B″, C″), and Grhl3+/cre-nZ; β-
catenin+/− (B‴, C‴). Grhl3; β-catenin double heterozygous mutant embryos exhibit spina biﬁda (B‴, C‴), whereas the Grhl3 single heterozygous mutant has no defects by appearance
(A). Moreover, the Grhl3cre-nZ/cre-nZ; β-catenin+/− embryos display exencephaly in addition to spina biﬁda and curled tail (A, B″, C″). (D, E) Detection of Grhl3-cre recombinase-active
cells labeled by GFP protein expression (green) with whole-mount immunohistochemistry. Grhl3-cre-nZmice, which were produced by the targeted insertion of the Cre gene into the
Grhl3 locus, are crossed with ROSA-GNZ mice (Stoller et al., 2008). Dorsal views of doubly transgenic offspring showing GFP expression only in the SE, not in the NE at the hindbrain
(D) and trunk (E) levels. (F, F′) The production of β-catenin deletion in Grhl3-positive SE by crossing β-cateninﬂox/+ or β-cateninﬂox/ﬂox with Grhl3-cre-nZmice. β-gal (GRHL3, green), β-
catenin (magenta), and nuclei (DAPI, blue). The expression of β-catenin proteins is speciﬁcally lost in the Grhl3-β-gal-positive cells of the conditional knockout embryo (F, F′; dotted
line). (G–I′) The grossmorphology (G–H′) and histology (I, I′) in thewild-type (G–I) and conditionalβ-catenin knockout (G′–I′) embryos at E10.5.β-catenin conditional knockout embryos
show spina biﬁda (G′–H′). (J, J′) Immunohistochemistry of β-catenin conditional knockout embryos. TROMAI (magenta), N-cadherin (blue), and nuclei (DAPI, green). Progenitor cells,
which express neither NE nor SE markers (green), are expanded by β-catenin conditional mutation (J′; arrows). Scale bars: 1 mm in B–C‴; 500 μm in G, G′; 300 μm in I, I′; 200 μm in
D, E, J, J′; 20 μm in F, F′.
524 C. Kimura-Yoshida et al. / EBioMedicine 2 (2015) 513–527plate border possesses an uncommitted progenitor character such
as Oct4, Klf5 and SSEA4 expression, which is speciﬁed into neither
NE nor SE, and loses this undifferentiated character at the time of
fusion (Fig. 1). Wnt antagonists DKK1/KREMEN1 contribute to the
maintenance of the uncommitted progenitor character and/or to the
avoidance of the SE speciﬁcation by canonical Wnt during neurulation(Figs. 1, 3, 4). The properly balanced cell fate speciﬁcation between NE
and SE cells within the neural plate border during neurulation might
lead to a progressive midline fusion of the neural folds and coincidental
separation of the neural tube and SE, whereas a failure in cell fate
speciﬁcation in the neural plate border/neural fold might lead to neural
tube defects (Fig. 9B).
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Fig. 9.A schematicmodel of fate speciﬁcation of uncommittedprogenitors in the neural plate border/neural folds being coordinately coupled to neural tube closure. (A) A schematicmodel
illustrating an intimate link between fate speciﬁcation of the uncommitted progenitor cells andneural tube closure. Prior to the fusion of neural folds, the neural plate border cells between
the NE (in blue) and SE (in yellow), which express DKK1/KREMEN1 (in red), are not speciﬁed into either the NE or SE fate as an uncommitted progenitor statemarked by OCT4, KLF5 and
SSEA4 (upper illustration). During the progression of neural tube closure, GRHL3-positive cells (in green) directed by canonicalWnt emerge coordinately in the vicinity of the neural plate
border toward the identical direction of the neuropore closure, and then DKK1/KREMEN1-positive cells (in red) become restricted to the opposite side, where the neuropore is still open
(lower illustration). (B) At the midline fusion of the neural folds, neural plate border cells lose the stem cell-like character and progressively specify into either SE or NE, regulated by ca-
nonical Wnt and its antagonists, respectively. In the Grhl3cre-nZ/cre-nZ and β-catenin conditional knockout embryos, uncommitted progenitor cells are expanded in the neural plate border
and consequently they result in hyperplasia of NE with hypoplasia of SE, and consequently, the neural tube fails to close correctly.
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fate speciﬁcation is altered, results in neural tube defects (Fig. 8G′–J′). Ad-
ditionally, the gain and loss ofDkk1 expression appear to affect the timing
of neural tube closure (Fig. S2; unpublished data; C.K.-Y. and I.M.). Thus,
we propose that the precise progressivemechanisms of fate speciﬁcation
in uncommitted progenitors involving canonicalWnt and its antagonists
may determine the correct neural tube closure via epithelial develop-
ment in the vertebrate embryo (Fig. 9).
Considering that cranial neural crest cells are delaminating from the
non-neural ectoderm in the vicinity of the neural plate border/neural
fold prior to neural tube closure in the mouse (Nichols, 1987; Weston
and Thiery, 2015), it can be questioned whether the neural crest isrelevant to uncommitted progenitor cells in the neural plate border
and whether its population is primarily affected in our studies. Our
study also supports the previous ﬁnding that a very few cranial neural
crest cells appear to delaminate from uncommitted progenitors within
the neural plate border at the forebrain level and from a considerable
amount of neural crest cells at the hindbrain level (Fig. 2F, G). However,
given that SOX9-negative uncommitted progenitor cells are still present
at both the forebrain and hindbrain levels and that trunk neural crest
cells emigrate from the dorsal neural tube after the completion of the
fate speciﬁcation of uncommitted progenitors (Fig. 2E–I), the decision
of fate speciﬁcation into neural crest cells appears to be not directly
linked to neural tube closure. Additionally,Grhl3-positive cells apparently
526 C. Kimura-Yoshida et al. / EBioMedicine 2 (2015) 513–527contribute to few neural crest cells in the Grhl3 heterozygous and homo-
zygous mutant embryos (Fig. 6G–M′).
Concurrent with these cell behaviors, the formation of neural crest
cells appeared not to be affected by Dkk1-misexpression or by Dkk1
and Grhl3 deﬁciency (Fig. 6G′–M′, Figs. S6, S7). Hence, although the
fate decisions of neural crest cells appear to be controlled by stage-
dependent differential responsiveness to canonical Wnt signaling acti-
vation after emigration in themouse embryo (Hari et al., 2012), it is like-
ly that the altered fate speciﬁcation through canonical Wnt observed in
this study is not due primarily to alterations of the fate decision of the
neural crest.
Grhl3 has been shown to play crucial roles in neural tube closure
(Gustavsson et al., 2008; Rifat et al., 2010). However, there is little
understanding of how Grhl3 expression is controlled during primary
neurulation. In the present study, Grhl3 was shown to be one of the
pivotal downstream effectors of canonical Wnt signaling for SE speciﬁ-
cation in uncommitted progenitors of the neural plate border/neural
fold (Figs. 6–9). This is in good agreement with the notion that
Grainyhead transcription factors play conserved roles in epidermal
differentiation in the animal kingdom (Wang and Samakovlis, 2012).
Disruption of Xenopus Grhl1 leads to defects in epidermal differentiation,
as evidenced by the loss of expression of the keratin gene (Tao et al.,
2005). Similarly, Xenopus Grhl3 activates speciﬁc markers of superﬁcial
epidermal cells in deep proliferating progenitor cells (Chalmers et al.,
2006). Mouse Grhl1-deﬁcient embryos display defects in skin and hair,
partly due to the reduction of desmosomal cadherins (Wilanowski
et al., 2008). Consistentwith thatﬁnding, in the present study the reduc-
tion of Grhl3 activity appeared to inhibit SE speciﬁcation (Figs. 6–8);
i.e., neural plate border cells marked by Grhl3-expression tend to trans-
form into NE cells in Grhl3-mutant embryos. These convergent lines of
evidence support the idea that Grhl3-positive cells will differentiate
into an SE fate by trans-activating SE-speciﬁc genes in a cell autonomous
fashion and, conversely, thatGrhl3-negative cellswill tend to becomeNE
cells in the neural plate border.
Grhl3 plays crucial roles in the speciﬁcation of SE fate of the uncom-
mitted neural plate border for neural tube closure. The epithelial fusion
and remodeling allow the reorganization of twomulticellular structures
spanning an anatomical and physiological gap to form a new, uniﬁed
structure. The process of epithelial fusion involves cellular protrusions
that extend from the leading edges of apposing SE cells (Waterman,
1976; Geelen and Langman, 1979; Pyrgaki et al., 2010). Indeed, ﬁne
structures of SE cells of the neural plate border appeared to be affected
in the Dkk1-misexpressing embryos (Fig. S3). Given that apposing
epithelial contact seems to be speciﬁc within neural folds, these cellular
behaviors may be initiated by Grhl3 as a crucial downstream effector of
canonical Wnt signaling.
Considering our hypothesis that the fate speciﬁcation of uncommitted
progenitors is crucial for neural tube closure, it can be argued that
Grhl3-deﬁcient embryos display neural tube defects solely at the level
of the caudal spinal cord and not at the forebrain and trunk levels (Rifat
et al., 2010; Ting et al., 2003). We assume that the roles of Grhl3 in fate
speciﬁcation might be complemented by Grhl2 expression redundantly
at the forebrain level (Fig. S8). To explore this possibility, we examined
Grhl2 expression in the Grhl3 mutant background and found that at
the forebrain level, Grhl2 expression extended locally to the most medial
SE (i.e., the neural plate border/neural fold) in theGrhl3-deﬁcient embry-
os (Fig. S8A–D, E–H′), whereas at the caudal level the compensatory
Grhl2 expression in the neural plate border/neural fold is not evident
(Fig. S8A–H).
Consistent with our hypothesis, the Grhl3-deﬁcient embryos
displayed cranial neural tube defects by the removal of one copy of
theGrhl2 gene dosage (Rifat et al., 2010). In addition, ourmisexpression
studies with Grhl2 revealed that Grhl2was able to induce the SE fate ec-
topically in the NE region (Fig. S8H′–P′), conﬁrming the compensatory
function of Grhl2 in place of Grhl3 for fate speciﬁcation during neurula-
tion. Consequently, we consider that the absence of both Grhl2 andGrhl3 expression in the neural plate border will cause neural tube
defects.
Thus, togetherwith the expression of stem cell markers andWnt an-
tagonists in the neural plate border (Figs. 1, 3), these ﬁndings lead us to
propose that the properly balanced fate speciﬁcation of uncommitted
progenitor cells in the neural plate border/neural fold by canonical
Wnt and one of its downstream effectors, Grhl3, may be crucial for
correct neural tube closure (Fig. 9).
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